Scientific Opinion on the substantiation of health claims related to astaxanthin and maintenance of joints, tendons, and connective tissue (ID 1918, 1978, 3142), protection of DNA, proteins and lipids from oxidative damage (ID 1449, 3141), maintenance of visual acuity (ID 1448), maintenance of blood cholesterol concentrations and maintenance of low plasma concentrations of C-reactive protein (ID 1450) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Meta data
Keywords
Astaxanthin, joints, tendons, connective tissue, oxidative damage, visual acuity, blood cholesterol, C-reactive protein, health claims.
On request from
European Commission
Question Number
EFSA-Q-2008-2185
EFSA-Q-2008-2186
EFSA-Q-2008-2187
EFSA-Q-2008-2651
EFSA-Q-2008-2711
EFSA-Q-2008-3873
EFSA-Q-2008-3874
Panel members at the time of adoption
Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen
Contact
Abstract
No abstract available
© European Food Safety Authority, 2009